
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cypress Ridge Capital is a venture capital firm founded to focus exclusively on the healthcare sector. Established in New York, New York, the firm has built a reputation for supporting innovative middle market companies in their pursuit of transformational growth opportunities. The principals of Cypress Ridge Capital possess nearly three decades of combined experience in the investment landscape, which has enabled them to deploy over $2 billion across more than 100 businesses.
Currently, Cypress Ridge Capital manages assets totaling $2 billion and has invested in over 100 portfolio companies. The firm emphasizes a thematic investment strategy that targets specific healthcare subsectors, aiming to build market-leading companies through both acquired and organic growth. Their office is located at 270 Madison Avenue, Suite 1805, New York, New York 10016.
Cypress Ridge Capital targets investments in a limited number of healthcare subsectors, including provider services, outsourced services, primary care, behavioral health, healthcare IT, and pharmaceutical services. The firm typically invests in companies with revenues ranging from $20 million to $100 million, making equity investments between $5 million and $75 million. This focus on middle market companies allows Cypress Ridge to identify and support transformational growth opportunities within the healthcare sector.
The firm employs a thematic investment strategy that emphasizes under-appreciated businesses and emerging market inflection points. Cypress Ridge Capital seeks to build market-leading companies through a combination of acquired and organic growth, ensuring that their portfolio aligns with their vision of supporting innovative healthcare solutions.
Cypress Ridge Capital has invested in over 100 companies within the healthcare sector. While specific portfolio companies are not listed, the firm’s focus on healthcare subsectors such as provider services, healthcare IT, and pharmaceutical services indicates a diverse range of investments. The firm’s strategy emphasizes identifying under-appreciated businesses that have the potential for significant growth.
Notable investments include companies that operate in behavioral health and primary care, sectors that are increasingly recognized for their importance in the healthcare landscape. Cypress Ridge Capital's commitment to these areas reflects its dedication to supporting transformational growth opportunities in healthcare.
Andrew Pardo - Managing Partner. Andrew has extensive experience in healthcare investments and has led numerous successful deals in the sector.
Christopher Petrini - Managing Partner. Christopher brings a wealth of knowledge in venture capital and has a strong track record in identifying growth opportunities.
Emily St. Thomas - Partner and COO. Emily oversees operations and plays a critical role in the firm's strategic direction.
Avi Sojitra - Vice President. Avi focuses on sourcing and evaluating investment opportunities within the healthcare sector.
Divya Rajagopal - Senior Associate. Divya supports the investment team in due diligence and portfolio management activities.
Cypress Ridge Capital prefers to receive pitches through their website, where founders can submit their business proposals. It is essential to include a comprehensive deck that outlines the business model, market analysis, and growth strategy. The firm typically reviews submissions and responds within a reasonable timeframe, although specific response times may vary.
Warm introductions are encouraged, as they can enhance the likelihood of receiving a favorable response. Founders should ensure that their presentations are clear and concise, focusing on the key elements that align with Cypress Ridge Capital's investment thesis.
Cypress Ridge Capital has been actively deploying capital, having invested over $2 billion across more than 100 businesses. The firm maintains a focus on transformational growth opportunities within the healthcare sector. However, no recent blog activity or specific updates have been detected.
As of now, there are no notable announcements or leadership changes reported. The firm continues to seek innovative healthcare solutions and emerging market trends to align with its investment strategy.
What are Cypress Ridge Capital's investment criteria?
Cypress Ridge Capital focuses on healthcare companies with revenues between $20 million and $100 million. They typically make equity investments ranging from $5 million to $75 million.
How can I apply or pitch to Cypress Ridge Capital?
Founders interested in pitching to Cypress Ridge Capital should prepare a detailed presentation that outlines their business model, market opportunity, and growth strategy. Direct inquiries can be made through their website.
What makes Cypress Ridge Capital different from other investors?
The firm specializes exclusively in healthcare, targeting under-appreciated businesses and emerging market inflection points. This focused approach allows them to identify unique investment opportunities that may be overlooked by other investors.
What is the geographic scope of Cypress Ridge Capital's investments?
Cypress Ridge Capital primarily invests in North America, concentrating on healthcare companies that fit their investment criteria.
What is Cypress Ridge Capital's post-investment involvement?
The firm actively supports its portfolio companies through strategic guidance and operational support, aiming to foster growth and enhance value creation.
What is the typical check size for investments?
Cypress Ridge Capital typically invests between $5 million and $75 million in their portfolio companies, depending on the specific needs and growth potential of the business.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.